title: Genotypic and allelic variability in CYP19A1 among populations of African and European ancestry.
abstract: CYP19A1 facilitates the bioconversion of estrogens from androgens. CYP19A1 intron single nucleotide polymorphisms (SNPs) may alter mRNA splicing, resulting in altered CYP19A1 activity, and potentially influencing disease susceptibility. Genetic studies of CYP19A1 SNPs have been well documented in populations of European ancestry; however, studies in populations of African ancestry are limited. In the present study, ten 'candidate' intronic SNPs in CYP19A1 from 125 African Americans (AA) and 277 European Americans (EA) were genotyped and their frequencies compared. Allele frequencies were also compared with HapMap and ASW 1000 Genomes populations. We observed significant differences in the minor allele frequencies between AA and EA in six of the ten SNPs including rs10459592 (p<0.0001), rs12908960 (p<0.0001), rs1902584 (p = 0.016), rs2470144 (p<0.0001), rs1961177 (p<0.0001), and rs6493497 (p = 0.003). While there were no significant differences in allele frequencies between EA and CEU in the HapMap population, a 1.2- to 19-fold difference in allele frequency for rs10459592 (p = 0.004), rs12908960 (p = 0.0006), rs1902584 (p<0.0001), rs2470144 (p = 0.0006), rs1961177 (p<0.0001), and rs6493497 (p = 0.0092) was observed between AA and the Yoruba (YRI) population. Linkage disequilibrium (LD) blocks and haplotype clusters that is unique to the EA population but not AA was also observed. In summary, we demonstrate that differences in the allele frequencies of CYP19A1 intron SNPs are not consistent between populations of African and European ancestry. Thus, investigations into whether CYP19A1 intron SNPs contribute to variations in cancer incidence, outcomes and pharmacological response seen in populations of different ancestry may prove beneficial.
authors: Department of Medical Genetics, University of Arkansas for Medical Sciences, Little Rock, AR 72205, United States of America.
authors: Athena
authors: A
authors: Starlard-Davenport
authors: Department of Epidemiology, College of Public Health, University of Arkansas for Medical Sciences, Little Rock, AR 72205, United States of America.
authors: Mohammed S
authors: MS
authors: Orloff
authors: Department of Biostatistics, University of Arkansas for Medical Sciences, Little Rock, AR 72205, United States of America.
authors: Ishwori
authors: I
authors: Dhakal
authors: Department of Environmental and Occupational Health, College of Public Health, University of Arkansas for Medical Sciences, Little Rock, AR 72205, United States of America.
authors: Rosalind B
authors: RB
authors: Penney
authors: Department of Medical Genetics, University of Arkansas for Medical Sciences, Little Rock, AR 72205, United States of America.
authors: Susan A
authors: SA
authors: Kadlubar
mesh_terms: D000483:Alleles; D001141:Aromatase / Q000235:genetics*; D044383:Black People / Q000235:genetics*; D005787:Gene Frequency; D060148:HapMap Project; D006239:Haplotypes; D006801:Humans; D007438:Introns; D015810:Linkage Disequilibrium; D020641:Polymorphism, Single Nucleotide; D044465:White People / Q000235:genetics*; D001741:Black or African American
chemical_list: D001141:Aromatase; C561410:CYP19A1 protein, human
references: Annu Rev Physiol. 2002;64:93-127
references: 11826265
references: Hum Reprod. 2002 Apr;17(4):897-902
references: 11925378
references: Hum Mol Genet. 2003 Apr 1;12(7):771-6
references: 12651872
references: Proc Natl Acad Sci U S A. 2003 May 13;100(10):6069-74
references: 12721363
references: Hum Mol Genet. 2003 Oct 15;12(20):2679-92
references: 12944421
references: Int J Cancer. 2005 Aug 20;116(2):267-74
references: 15800924
references: Am J Epidemiol. 2007 Feb 1;165(3):235-45
references: 17110639
references: Cancer Res. 2007 Mar 1;67(5):1893-7
references: 17325027
references: Cancer Epidemiol Biomarkers Prev. 2008 Jan;17(1):27-32
references: 18199708
references: Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):242-7
references: 19124504
references: Nucleic Acids Res. 2009 May;37(9):e67
references: 19339519
references: Nature. 2009 Sep 10;461(7261):206-11
references: 19741701
references: Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2734-44
references: 19789370
references: Cancer Res. 2010 Jan 1;70(1):319-28
references: 20048079
references: J Hum Genet. 2010 Mar;55(3):189-93
references: 20186154
references: Endokrynol Pol. 2010 Jan-Feb;61(1):126-34
references: 20205115
references: Hum Genomics. 2010 Jun;4(5):284-8
references: 20650817
references: Hum Genomics. 2010 Jun;4(5):289-301
references: 20650818
references: Carcinogenesis. 2010 Oct;31(10):1794-9
references: 20688833
references: Neuroscience. 2011 Feb 3;174:151-9
references: 21115103
references: Eur J Hum Genet. 2011 Mar;19(3):363-6
references: 21119710
references: Cancer Chemother Pharmacol. 2011 Nov;68(5):1263-71
references: 21442439
references: Cancer Causes Control. 2011 Jul;22(7):955-63
references: 21479914
references: BMC Med Genet. 2011 May 31;12:78
references: 21627810
references: Mol Med Rep. 2012 Jan;5(1):245-9
references: 21972004
references: J Alzheimers Dis. 2012;28(3):601-12
references: 22057025
references: Nucleic Acids Res. 2012 Jan;40(Database issue):D930-4
references: 22064851
references: Am J Orthod Dentofacial Orthop. 2012 Nov;142(5):662-70
references: 23116507
references: J Neurotrauma. 2013 Aug 15;30(16):1415-25
references: 23540392
references: Med Oncol. 2013;30(3):665
references: 23893151
references: Ann Surg Oncol. 2014 Mar;21(3):939-45
references: 24242679
references: Tumour Biol. 2014 May;35(5):4517-27
references: 24430361
references: BMC Genomics. 2014 Jun 06;15:437
references: 24906912
references: Nucleic Acids Res. 1998 Jan 1;26(1):362-7
references: 9399875